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ABSTRACT 
Cisplatin (CDDP) is an effective antineoplastic agent in the treatment of solid malignant tumors. But, its clinical use is limited because of various side 
effects including sensorineural hearing loss. Several agents have been proposed to reduce these side effects.  The present study reported that the 
etanolic extract of Abutilon indicum scavenge superoxide and hydroxyl radicals, resulting in a reduction of lipid peroxidation. The purpose of the 
present study was to evaluate EEAI’s efficacy as a protective agent against cisplatin-induced ototoxicity. Albino wistar rats were used in this study 
and were divided into five treatment groups: 1) animals administered 2% v/v aqueous tween 80 solution (5ml/kg, p.o) – control sroup(Group I), 2) 
animals administered 2% v/v aqueous tween 80 solution (5ml/kg, p.o) + 6 mg/kg via the                                               i.p route of Cisplatin (Group II), 3) 
animals received Cystone (5ml/kg, p.o) [Standard] (Group III), 4) animals received 200 mg/kg EEAI suspended in 2% v/v aqueous tween 80 
solution, p.o + 6 mg/kg, i.p of cisplatin (Group IV), 5) animals received 400 mg/kg EEAI suspended in 2% v/v aqueous tween 80 solution, p.o 6 
mg/kg, i.p of cisplatin (Group V). The protective effect of EEAI on CDDP-induced nephrotoxicity was evaluated. Nephrotoxicity was evaluated by 
means of measurement of serum BUN and creatinine and histopathological examination of the kidney. There were significant differences in serum 
BUN and creatinine levels between control Group and cisplatin treated Groups. The result suggested that EEAI at 200 and 400mg/kg administered 7 
days before cisplatin treatment significantly prevented the increase of serum creatinine, blood urea nitrogen, uric acid, total proteins, total 
cholesterol, alkaline phosphatase, and albumin concentrations and markedly decreased cisplatin-induced renal damage as confirmed by 
biochemical assays and histopathological studies.  
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INTRODUCTION 
Cisplatin  (cis-diaminedichloroplatinum II) is one of the most 
effective chemotherapeutic agents and plays a major role in the 
treatment of a variety of human solid tumors including those of the 
head, neck, testis, ovary, and breast.1 The nephrotoxicity of cisplatin 
limits the efficacy of this important anticancer drug as its 
pathogenesis induced acute renal failure (ARF).2 The molecular 
mechanisms of its toxicity are poorly understood. Studies have 
suggested that free radical like superoxide radical play an important 
role in cisplatin-induced nephrotoxicity.3 It has also been proposed 
that increase in lipid peroxidation in the kidney is also associated 
with cisplatin-induced nephrotoxicity.4 Cisplatin also induces 
nephrotoxicity by causing GSH depletion which inhibit antioxidant 
activity.5Based on the pathophysiological role of cisplatin (CDDP) 
Nephrotoxicity it has been studied for the last three decades. 
Oxidative stress, inflammation and apoptosis are the main factors of 
the CDDP-induced renal injury.6-9 
In CDDP-induced nephrotoxicity, platinum-glutathione (GSH) 
conjugates formed in cells were metabolized through a gamma-
glutamyltranspeptidase (GGT) to a reactive thiol, which is a potent 
nephrotoxin, and depleted GSH impairs regulation of reactive 
oxygen species (ROS).10 In addition, oxidative stress is well known 
to stimulate transcription factors, including nuclear factor-kappa B 
(NF-kB). Consequently, NF-kB activation leads to expression of many 
gene involved in the renal damages such as inducible nitric oxide 
synthase (iNOS) and proinflammatory cytokine gene, resulting in 
excessive nitric oxide (NO) generation.11The side effects of cisplatin 
include nephrotoxicity, gastrointestinal toxicity, neurotoxicity, 
ototoxicity. Some evidence suggests that the antioxidant DPPD (N,N-
diphenylpphenylenediamine) inhibited nephrotoxicity in cisplatin 
treated rats, by reducing the increase in lipid peroxide level, and also 
by reducing the inhibition of p-aminohippurate transport in-
vitro.12Thus, our study is carried on screening program to evaluate 
the protective potentials of natural compounds. The objective of the 
present study is to explore the protective effect of Abutilon indicum 
L. (Malvaceae) extracts in Cisplatin induced renal injury in rats.13 
 
Materials and methods 
Plant material 
The plant Abutilon indicumL. (Malvaceae) is widely distributed 
throughout South India. Abutilon indicumL. was collected from 
Tirumalahills,Tirupati, India in the month of December and it was 
identified and authenticated. The taxonomical identification and 
authentication was done by Dr. K. Madhava Chetty, Assistant 
Professor, Department of Botany, S.V. University, Tirupati. About 
500 g of dried powder of Abutilon indicum was successively 
extracted with petroleum ether (60-800C) for 8 hrs. to remove the 
fatty matter. The defatted marc was then subjected to soxhlet 
extraction with 95% ethanol to obtain ethanolic extract.14After 
complete exhaustion of the drug it was filtered and the filtrate was 
concentrated on water bath (450C) to remove the solvent and to get 
a sticky brown coloured extract i.e. ethanolic extract of Abutilon 
indicum. Aqueous extract was prepared by macerating the dried 
drug powder in double distilled water. The extract was concentrated 
in a water bath and stored in desiccators.15 
Animals:Adult Albino Wistar rats weighing about 150-180 g of either 
sex were procured from the animal house of SreeVidyanikethan 
College of Pharmacy, Tirupati. The animals were maintained in a 
well-ventilated animal house approved by Committee For The 
Purpose of Control and Supervision of Experiments on Animals 
(CPCSEA), with 12:12 hour light/dark cycle in propylene cages with 
27± 2oC temperature. The animals were given standard pellet. 
Acute oral toxicity study: The study was followed by using OECD- 
423 (Acute Toxic Class Method). Adult Wistar rats weighing 150- 
180g were used for the study. The starting dose level of EEAI was 
2000mg/kg body weight p. o. volume was administered to overnight 
fasted rats with ad libitum. Food was withheld for further 3- 4 hours 
after administration of EEAI and observed for signs for toxicity. The 
body weight of the rats before and after administration were noted 
that changes in skin and fur, eyes, mucous membranes, respiratory, 
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circulatory, autonomic and central nervous system and motor 
activity and behavior pattern were observed and also sign of 
tremors, convulsions, salivation, diarrhea, lethargy, sleep and coma 
were noted. 
Nephroprotective study 
Method:Five groups of six rats in each were fasted and deprived of 
water for eighteen hours prior to the experiment. The first group of 
animals serving as control, received 2% v/v aqueous tween 80 
solution (5ml/kg, p.o); the second group received 2% v/v aqueous 
tween 80 solution (5ml/kg, p.o) along with 6 mg/kg/i.p; the third 
group received cystone (5ml/kg, p.o); the fourth, fifth groups 
received the EEAI at the doses of 200 mg/kg and 400 mg/kg body 
weight orally daily for seven days respectively for six days, starting 3 
days before cisplatin injection(Table 1). The biochemical parameters 
were estimated 24 hrs following the last dose. 
Table 1: Experimental design 
 
Biochemical analysis: Blood samples were collected by cardiac 
puncture under diethyletheranaesthesia, using 21 guage (21 G) 
mounted on a 5ml syringe (Hindusthan syringes and medical devices 
ltd, Faridabad, India.). Serum samples were analyzed for creatinine, 
blood urea nitrogen (BUN), uric acid, total protein, albumin, alkaline 
phosphatase, total cholesterol.16 
Histopathological analysis: After the animals were sacrificed, the 
kidney samples were excised from the control and treated groups of 
animals and washed them with normal saline.17They were fixed in 
10% buffered formalin for 24 h and embedded in paraffin wax. 
Cross- sections of the kidney tissue (5-6µm thick) were prepared 
and stained with haematoxylin-eosin dye. The sections were 
evaluated by microscopical examination.18 
Statistical analysis: Values are expressed as mean ± SEM. Statistical 
analysis was performed by one-way analysis of variance (ANOVA) 
followed by Duncan’s Multiple Range Test (DMRT). The values were 
considered statistically significant if the P- value is less than 0.05.19 
RESULTS AND DISCUSSION 
Cisplatin is an extensively used anti-cancer agent for the 
management of germ cell tumours, head and neck cancers, bladder 
cancer, cervical cancer and as a slavage in the treatment of other 
solid tumours.20Although higher doses of cisplatin are more 
efficacious for the suppression of cancer, high dose therapy 
manifests irreversible renal damage. A number of therapeutic agents 
have been evaluated experimentally and clinically against cisplatin-
induced nephrotoxicity, but none of them proved to be clinically 
effective as a complete protective agent.21 Cisplatin therapy induces 
oxidative stress, principally involving ROS, in renal proximal tubular 
cells.22 Oxidative stress caused by various free oxygen radicals 
including superoxide anion, hydrogen peroxide and hydroxyl radical. 
The interaction of ROS with cellular components may result in 
damage to DNA, proteins and lipids.23 The protective effects of EEAI 
may be partially mediated by preventing the cisplatin-induced 
decline of renal anti oxidant status.24 In this study, single 
intraperitoneal administration of 5mg/kg of cisplatin to rats induced 
significant increase in serum creatinine, blood urea nitrogen, uric 
acid, total proteins, total cholesterol, alkaline phosphatase, and 
albumin concentrations compared to control animals, suggesting an 
acute renal failure. 
The acute toxic class method is a step wise procedure with three 
animals of a single sex per step. Depending on the mortality or 
moribund status of the animals and the average two to three steps 
may be necessary to allow judgment on the acute toxicity of the test 
substance. Acute toxicity studies showed that the body weight of the 
rats before and after administration was noted and the changes in 
the body weight were not so prominent. No changes in skin and fur, 
eyes, mucous membranes, respiratory, circulatory, autonomic and 
central nervous system and motor activity and behavior pattern 
were observed and also sign of tremors, convulsions, salivation, 
diarrhea, lethargy, sleep and coma were noted. The onset of toxicity 
and signs of toxicity were also not observed. In further study there 
was no toxicity / death observed at these levels.Serum analysis for 
creatinine, blood urea nitrogen, uric acid, total proteins, total 
cholesterol, alkaline phosphatase, and albumin were analyzed after 
cisplatin induced toxicity and the protective potential of Abutilon 
indicumextract in rats. The histopathology study for kidney was also 
carried out to assess the protective effect of Abutilon indicum. 
Table 2: Effect of EEAI on serum parameters with/without 
Cisplatin treatment 
 
Values are expressed as mean ± SEM of six different samples; P<0.05 
compared with control by Duncan’s Multiple Range Test (DMRT). 
 
Fig 1: Effect of EEAI on serum creatinine levels in cisplatin 
induced nephrotoxic rats 
Lakshmi. S et al. 





Fig 2: Effect of EEAI on blood urea nitrogen levels in cisplatin 
induced nephrotoxic rats 
 
Fig 3: Effect of EEAI on serum uric acid levels in cisplatin 
induced nephrotoxic rats 
 
 
Fig 4: Effect of EEAI on serum total protein levels in cisplatin 
induced nephrotoxic rats 
 
Fig 5: Effect of EEAI on serum total cholesterol levels in cisplatin 
induced nephrotoxic rats 
 
 
Fig 6: Effect of EEAI on serum alkaline phosphate levels in 
cisplatin induced nephrotoxic rats 
 
Fig 7: Effect of EEAI on serum albumin levels in cisplatin 
induced nephrotoxic rats 
 
Histopathological studies of the kidney in cisplatin induced 
nephrotoxic rats 
 
Fig 8: Histopathology of rat kidney in control group (10X) 
 
Fig 9: Histopathology of rat kidney in cisplatin (6mg/kg) 
treated group (10X) 
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Fig 10: Histopathology of rat kidney in standard (cystone- 
5ml/kg) treated group (10X) 
 
Fig 11:  Histopathology of rat kidney in EEAI (200mg/kg) + 
cisplatin (6mg/kg) treated group (10X) 
 
Fig 12: Histopathology of rat kidney in EEAI (400mg/kg) + 
cisplatin (6mg/kg) treated group (10X) 
The administration of Cisplatin to control rats caused significant 
increase in serum creatinine, blood urea nitrogen, Serum uric acid, 
serum total proteins, total cholesterol, Serum alkaline phosphatase 
and serum albumin concentrations. EEAI pretreatment dose-
dependently attenuated these cisplatin induced elevations in serum 
(p < 0.05) Histological analysis of the kidneys showed that cisplatin 
administration caused severe and widespread necrosis with 
dilatation of proximal tubules, vacuolization, tubular cell 
desquamation and intraluminal cast formation. Cisplatin induced 
histopathological renal changes were minimal in animals received 
EEAI. 
CONCLUSION 
In this study, single intraperitoneal administration of 5mg/kg of 
cisplatin to rats induced significant increase in serum creatinine, 
blood urea nitrogen, uric acid, total proteins, total cholesterol, 
alkaline phosphatase, and albumin concentrations compared to 
control animals, suggesting an acute renal failure. EEAI at 200 and 
400mg/kg administered 7 days before cisplatin treatment 
significantly prevented the increase of serum creatinine, blood urea 
nitrogen, uric acid, total proteins, total cholesterol, alkaline 
phosphatase, and albumin concentrations and markedly decreased 
cisplatin-induced renal damage as confirmed by biochemical assays 
and histopathological studies. In the present study, EEAI revealed 
potent protective activity against cisplatin-induced nephrotoxicity, 
therefore, renal protective action of EEAI may be beneficial for 
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